Bender Jeremy Insider Trading Activity (AURA)

Profile

Jeremy Bender is the Chief Executive Officer of Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing targeted therapies for genetically defined cancers, particularly in pediatric patients. He has been involved in the company since its inception and has contributed to its mission of addressing the needs of underserved populations in cancer treatment.

Role	Insider
Notability	30/100

Board memberships

Day One Biopharmaceuticals, Inc.

Awards & honors

Leadership in clinical development for pediatric cancer therapies
CEO of Day One Biopharmaceuticals

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-07-08	AURA	Aura Biosciences, Inc.	A — Grant or award	30.0K	$0.00
2026-04-23	DAWN	Day One Biopharmaceuticals, Inc.	D — Derivative transaction	808.3K	—
2026-04-23	DAWN	Day One Biopharmaceuticals, Inc.	D — Derivative transaction	300.0K	—
2026-04-23	DAWN	Day One Biopharmaceuticals, Inc.	D — Derivative transaction	18.2K	—
2026-04-23	DAWN	Day One Biopharmaceuticals, Inc.	D — Derivative transaction	147.7K	—
2026-04-23	DAWN	Day One Biopharmaceuticals, Inc.	D — Derivative transaction	300.0K	—
2026-04-23	DAWN	Day One Biopharmaceuticals, Inc.	D — Derivative transaction	20.2K	—
2026-04-23	DAWN	Day One Biopharmaceuticals, Inc.	D — Derivative transaction	204.6K	—
2026-02-18	DAWN	Day One Biopharmaceuticals, Inc.	S — Open-market sale	15.5K	$11.60	$179K
2026-02-18	DAWN	Day One Biopharmaceuticals, Inc.	M — Option exercise	14.8K	—
2026-02-18	DAWN	Day One Biopharmaceuticals, Inc.	M — Option exercise	11.7K	—
2026-02-18	DAWN	Day One Biopharmaceuticals, Inc.	M — Option exercise	11.7K	—
2026-02-18	DAWN	Day One Biopharmaceuticals, Inc.	M — Option exercise	4.8K	—
2025-08-15	DAWN	Day One Biopharmaceuticals, Inc.	S — Open-market sale	16.1K	$6.77	$109K
2025-08-15	DAWN	Day One Biopharmaceuticals, Inc.	M — Option exercise	11.7K	—
2025-08-15	DAWN	Day One Biopharmaceuticals, Inc.	M — Option exercise	11.7K	—
2025-08-15	DAWN	Day One Biopharmaceuticals, Inc.	M — Option exercise	4.8K	—
2025-08-15	DAWN	Day One Biopharmaceuticals, Inc.	M — Option exercise	3.6K	—
2025-07-10	DAWN	Day One Biopharmaceuticals, Inc.	G — Bona-fide gift	179.4K	$0.00
2025-07-10	DAWN	Day One Biopharmaceuticals, Inc.	G — Bona-fide gift	179.4K	$0.00

Frequently Asked Questions

Who is Bender Jeremy?

How many SEC Form 4 filings has Bender Jeremy submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Bender Jeremy been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($427K) across all tracked filings.

Where can I see all of Bender Jeremy's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Bender Jeremy — SEC Form 4 Insider Trading Activity

Summary